Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada

J Acquir Immune Defic Syndr. 2018 May 1;78(1):e1-e3. doi: 10.1097/QAI.0000000000001649.

Authors

Hezhao Ji^{1

2}, Aileen Patterson¹, Tracy Taylor¹, Claudia Rank³, Jessica Halverson³, Rupert Capina¹, James Brooks¹, Paul Sandstrom^{1

2}

Affiliations

¹ National Microbiology Laboratory at JC Wilt Infectious Disease Research Center, Public Health Agency of Canada, Winnipeg, Canada.
² Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
³ Surveillance and Epidemiology Division, Public Health Agency of Canada, Ottawa, Canada.

No abstract available

Publication types

Letter

MeSH terms

Canada
Drug Resistance, Viral / drug effects*
Drug Resistance, Viral / genetics
HIV Infections / drug therapy
HIV Infections / epidemiology*
HIV Infections / virology
HIV Integrase / genetics*
HIV Integrase / metabolism
HIV Integrase Inhibitors / pharmacology*
HIV-1 / drug effects*
HIV-1 / enzymology
HIV-1 / genetics
Humans
Mutation
Polymorphism, Genetic
Prevalence

Substances

HIV Integrase Inhibitors
HIV Integrase